Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Right Ventricular Septal Biopsy to Detect Cardiac Amyloidosis in At-Risk Population: A Prospective Study

NCT07784712 is registered in ClinicalTrials.gov with Geisinger Clinic as lead sponsor.

NCT NCT07784712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07784712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Right Ventricular Septal Biopsy to Detect Cardiac Amyloidosis in At-Risk Population: A Prospective Study
Lead sponsor
Geisinger Clinic
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
August 31, 2028
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

attr-cm (transthyretin amyloid cardiomyopathy), heart failure